Vaxart, Inc.
(NASDAQ : VXRT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
2.95%201.351.2%$534.26m
GILDGilead Sciences, Inc.
3.92%75.630.9%$477.78m
BIIBBiogen Inc.
2.20%335.641.3%$393.13m
CELGCelgene Corporation
2.57%83.931.2%$347.89m
ILMNIllumina, Inc.
3.57%324.603.5%$308.28m
REGNRegeneron Pharmaceuticals, Inc.
5.45%398.142.6%$240.95m
ALXNAlexion Pharmaceuticals, Inc.
4.87%127.412.0%$225.56m
VRTXVertex Pharmaceuticals Incorporated
3.88%184.551.9%$218.66m
SRPTSarepta Therapeutics, Inc.
5.15%138.1016.4%$179.92m
AAgilent Technologies, Inc.
2.58%67.321.5%$161.53m
BMRNBioMarin Pharmaceutical Inc.
6.43%105.844.4%$144.07m
LGNDLigand Pharmaceuticals Incorporated
5.53%211.1423.3%$121.74m
VKTXViking Therapeutics, Inc.
6.27%15.090.9%$119.05m
NKTRNektar Therapeutics
3.26%50.685.6%$112.61m
EXASExact Sciences Corporation
2.67%67.5325.3%$105.78m

Company Profile

Vaxart, Inc. is engaged in the development of vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.